Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors

2 Aug 2022

Abstract excerpt

CONTEXT.—: Special AT-rich sequence-binding protein 2 (SATB2) induces local chromatin loops to facilitate transcription. SATB2 immunostaining is commonly used as a marker for colorectal adenocarcinoma and osteosarcoma. OBJECTIVE.—: To extend our knowledge on the diagnostic value of SATB2 analysis in a comprehensive set of human tumors. DESIGN.—: Tissue microarrays with 15 012 samples from 120 tumor types and 608...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Digestive system and related health
Share to Genetic factors in colorectal cancer
Share to Genomics and Chromatin Dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35917493
DOI: 10.5858/arpa.2021-0317-oa

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsPMID 35917493Read ↗

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasSemantic proximity Read ↗

SATB2 is a novel biomarker and therapeutic target for cancerSemantic proximity Read ↗

YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell CarcinomaSemantic proximity Read ↗

Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinomaSemantic proximity Read ↗

Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.Semantic proximity Read ↗

SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in MesotheliomaSemantic proximity Read ↗

SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Semantic proximity Read ↗

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.Semantic proximity Read ↗

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study.Semantic proximity Read ↗

Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancerSemantic proximity Read ↗

Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.Semantic proximity Read ↗

Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic PitfallSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.